Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Nov 17, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PTC | PTC INC | NASDAQ | Software - Application | A | $21.52B | $179.61 | 2.89% | $885.58M | 42.16x | 0.77 | United States | 46 |
| TPR | TAPESTRY INC | NYSE | Luxury Goods | A | $20.75B | $101.41 | 0.65% | $598.20M | 74.57x | 14.93 | United States | 36 |
| NBIX | NEUROCRINE BIOSCIENCES INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $14.44B | $144.86 | 0.48% | $679.20M | 33.61x | 0.42 | United States | 52 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | A | $8.57B | $141.07 | -0.45% | $182.64M | -23.55x | 1.87 | Ireland | 16 |
| PRIM | PRIMORIS SERVICES CORP | NYSE | Engineering & Construction | A | $6.38B | $118.04 | 1.38% | $513.21M | 23.01x | 1.86 | United States | 54 |
| SGHC | SUPER GROUP (SGHC) LTD | NYSE | Gambling | A | $6.20B | $12.25 | -0.41% | N/A | 24.60x | 0.60 | Guernsey | 32 |
| GTES | GATES INDUSTRIAL CORP PLC | NYSE | Specialty Industrial Machinery | A | $5.70B | $22.07 | -1.78% | $672.10M | 23.99x | 1.02 | United States | 37 |
| RSI | RUSH STREET INTERACTIVE INC | NYSE | Gambling | A | $3.96B | $17.24 | -0.63% | -$33.04M | 52.24x | 2.40 | United States | 50 |
| MIRM | MIRUM PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $3.67B | $71.44 | 3.16% | -$592.00k | -84.05x | 1.69 | United States | 26 |
| TPC | TUTOR PERINI CORP | NYSE | Engineering & Construction | A | $3.12B | $59.08 | -0.94% | $108.27M | -109.41x | 3.28 | United States | 28 |
| FOLD | AMICUS THERAPEUTICS INC | NASDAQ | Biotechnology | A | $2.92B | $9.48 | 1.07% | $59.28M | -237.00x | 2.77 | United States | 23 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $2.58B | $45.00 | 1.26% | $64.66M | -136.36x | 0.35 | United States | 28 |
| SPNT | SIRIUSPOINT LTD | NYSE | Insurance - Reinsurance | A | $2.37B | $20.33 | 1.30% | $339.10M | 12.25x | 4.64 | Bermuda | 30 |
| HCI | HCI GROUP INC | NYSE | Insurance - Property & Casualty | A | $2.33B | $179.99 | -2.06% | $301.16M | 10.43x | 1.82 | United States | 50 |
| IHS | IHS HOLDING LTD | NYSE | Telecom Services | A | $2.09B | $6.24 | -2.95% | N/A | 4.46x | -34.21 | United Kingdom | 30 |
| PGY | PAGAYA TECHNOLOGIES LTD | NASDAQ | Software - Infrastructure | A | $1.97B | $23.92 | 2.22% | -$155.79M | -8.73x | 2.03 | Israel | 21 |
| BLBD | BLUE BIRD CORP | NASDAQ | Auto Manufacturers | A | $1.62B | $51.17 | -1.41% | $175.74M | 14.10x | 1.59 | United States | 46 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $1.49B | $7.08 | 2.61% | $83.87M | -141.60x | -2.15 | United States | 17 |
| CRTO | CRITEO SA | NASDAQ | Advertising Agencies | A | $1.09B | $20.77 | -3.62% | $219.28M | 6.66x | 0.79 | France | 51 |
| ANAB | ANAPTYSBIO INC | NASDAQ | Biotechnology | A | $936.42M | $33.82 | 1.68% | -$82.14M | -12.34x | -13.00 | United States | 15 |
| ORGO | ORGANOGENESIS HOLDINGS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $774.16M | $6.10 | -1.77% | $18.04M | -50.83x | 0.49 | United States | 21 |
| UDMY | UDEMY INC | NASDAQ | Education & Training Services | A | $758.23M | $5.18 | -0.58% | $28.86M | -172.67x | 1.79 | United States | 23 |
| BWMN | BOWMAN CONSULTING GROUP LTD | NASDAQ | Engineering & Construction | A | $600.59M | $34.57 | 1.20% | $38.00M | 35.28x | 0.95 | United States | 53 |
| AKBA | AKEBIA THERAPEUTICS INC | NASDAQ | Biotechnology | A | $443.16M | $1.67 | -5.11% | $25.70M | -20.88x | 7.76 | United States | 25 |
| OPRX | OPTIMIZERX CORP | NASDAQ | Health Information Services | A | $282.97M | $15.18 | -1.81% | $11.65M | N/A | 0.39 | United States | 29 |
| EGHT | 8X8 INC | NASDAQ | Software - Application | A | $270.35M | $1.95 | -1.02% | $51.06M | -48.75x | 4.04 | United States | 16 |
| ELMD | ELECTROMED INC | NYSEMKT | Medical Devices | A | $210.77M | $25.27 | -4.10% | $12.05M | 26.05x | 0.20 | United States | 57 |
| CXDO | CREXENDO INC | NASDAQ | Telecom Services | A | $209.28M | $6.81 | 0.44% | $7.94M | 45.40x | 0.24 | United States | 42 |
| INFU | INFUSYSTEM HOLDINGS INC | NYSEMKT | Medical Instruments & Supplies | A | $193.40M | $9.51 | -6.40% | $24.16M | 36.58x | 0.78 | United States | 45 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.